Sort
85,873 grants matching “alzheimers”
Epidemiology of Dementia in Cache County, Utah
$2,135,743Kathleen Anne Welsh-Bohmer · Duke University · R01 · FY2006 · AG
Einstein Aging Study
$2,135,153Richard B. Lipton · Albert Einstein College Of Medicine · P01 · FY2014 · AG
A Follow-up Study for Causes of Cancer in Black Women
$2,134,694Julie R Palmer · Boston University Medical Campus · U01 · FY2022 · CA
Phenotyping Core
$2,134,539Thomas T Perls · Washington University · U19 · FY2023 · AG
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial
$2,133,795Joe Verghese · Albert Einstein College Of Medicine · U01 · FY2022 · NS
IMPACT-ADRD: Investigating the Multi-omics Perturbations Associated with Complex Environmental Toxicants and their Contribution to Alzheimer's Disease and Related Dementias
$2,133,773Anke Huels · Emory University · U01 · FY2025 · AG
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia
$2,133,267Xiaobo Mao · Johns Hopkins University · RF1 · FY2022 · NS
The convergence of stress and sex on Abeta and tau metabolism and pathology
$2,133,060John R Cirrito · Washington University · RF1 · FY2023 · AG
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration
$2,132,716Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2023 · AG
VIral and host mechanisms that tilt the HSV lytic/latent balance
$2,130,974Donald M Coen · Harvard Medical School · P01 · FY2020 · AI
Center of Biomedical Research Excellence in CNS Metabolism
$2,130,945Patrick G Sullivan · University Of Kentucky · P20 · FY2024 · GM
Tau-induced connectome imaging markers of Alzheimer's disease
$2,130,568Yonggang Shi · University Of Southern California · RF1 · FY2020 · AG
Indiana Alzheimer Disease Center
$2,130,441Andrew J Saykin · Indiana University Indianapolis · P30 · FY2020 · AG
Indiana Alzheimer Disease Center
$2,130,441Andrew J Saykin · Indiana University Indianapolis · P30 · FY2019 · AG
Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies
$2,130,169Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Association of the in Utero Exposome with Life-Course Cognition and Prodromal Alzheimer's Disease in Midlife.
$2,130,150Barbara A Cohn · Public Health Institute · RF1 · FY2022 · NS
Neuroinflammation, Inflammatory Challenge, and Memory
$2,130,074Ruth M Barrientos · Ohio State University · RF1 · FY2018 · AG
VIral and host mechanisms that tilt the HSV lytic/latent balance
$2,129,998Donald M Coen · Harvard Medical School · P01 · FY2021 · AI
VIral and host mechanisms that tilt the HSV lytic/latent balance
$2,129,998Donald M Coen · Harvard Medical School · P01 · FY2022 · AI
VIral and host mechanisms that tilt the HSV lytic/latent balance
$2,129,998David M Knipe · Harvard Medical School · P01 · FY2023 · AI
AAV-mediated Interrogation of the Brain FSH Receptor
$2,129,396Tony Yuen · Icahn School Of Medicine At Mount Sinai · R61 · FY2025 · AG
UHC/CWRU ALZHEIMER'S DISEASE RESEARCH CENTER
$2,129,166Case Western Reserve University · P50 · FY2002 · AG
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,128,853Colin Masters · University Of Melbourne · R01 · FY2020 · AG
Potentiate Cav3.3 To Treat Cognitive Deficits Associated with Impaired Sleep Spindle
$2,128,784Jen Qian Pan · Broad Institute, Inc. · RF1 · FY2025 · MH
Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD
$2,128,281Chinedu Theresa Udeh-Momoh · Wake Forest University Health Sciences · R01 · FY2023 · AG